Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

PI3K inhibitor, preparation method and application thereof in pharmacy

A technology of inhibitors and drugs, applied in the field of medicine

Inactive Publication Date: 2016-11-16
FUDAN UNIV
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to reasons such as toxicity, solubility and stability, it failed to enter clinical trials (Kong D et al., J.Curr.Med.Chem., 2009,16(22)2839-2854)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PI3K inhibitor, preparation method and application thereof in pharmacy
  • PI3K inhibitor, preparation method and application thereof in pharmacy
  • PI3K inhibitor, preparation method and application thereof in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0093] N-[2-Chloro-5-(quinolin-3-yl)pyridin-3-yl]benzenesulfonamide (Compound 1)

[0094]

[0095] 1: Preparation of N-(2-chloro-5-bromopyridin-3-yl)benzenesulfonamide (1-J)

[0096]

[0097] In a 100mL round bottom flask, add dichloromethane (DCM) (50mL), 3-amino-2-chloro-5-bromopyridine (B1) (5.0g, 24.0mmol), pyridine (3.8g, 48mmol), ice Under cooling in a water bath, benzenesulfonyl chloride (D1) (5.3 g, 31 mmol) was added dropwise. The reaction solution was slowly raised to room temperature, stirred for 24 h, followed by HPLC. After the reaction, pour it into water (30mL), separate the layers, wash the organic phase with saturated aqueous citric acid solution (50ml), saturated sodium bicarbonate (50ml), and saturated brine, dry over anhydrous sodium sulfate, filter, and concentrate to remove DCM, a solid precipitated out. Recrystallization with petroleum ether (PE) / DCM gave light white solid product N-(2-chloro-5-bromopyridin-3-yl)benzenesulfonamide (1-J), MS (ESI...

Embodiment 2

[0105] N-[2-Chloro-5-(quinolin-3-yl)pyridin-3-yl]benzenesulfonamide (Compound 2)

[0106]

[0107] Preparation of N-[2-chloro-5-(quinolin-6-yl)pyridin-3-yl]benzenesulfonamide (compound 2)

[0108]

[0109] The experimental procedure is the same as the synthesis of compound 1 in Example 1, except that 3-bromoquinoline (Q3) is replaced by 6-bromoquinoline (Q6) to obtain compound 2. MS(ESI positive ion)m / z:396.86(M+1),1HNMR(400MHz,CDCl 3): δppm3.857(s, 1H), 7.504(t, J=7.6Hz, 2H), 7.597-7.616(m, 1H), 7.831-7.851(m, 2H), 7.903(d, J=8.0Hz, 1H), 8.010(d, J=8.0Hz, 1H), 8.236-8.284(m, 2H), 8.343(d, 2.8Hz, 2H), 8.477(d, J=2.0Hz, 1H), 8.991(d, J=4.0Hz, 1H).

Embodiment 3

[0111] N-{2-chloro-5-[1H-pyrrole(2,3-b)pyridin-5-yl]pyridin-3-yl}benzenesulfonamide (Compound 3)

[0112]

[0113] Preparation of N-{2-chloro-5-[1H-pyrrole(2,3-b)pyridin-5-yl]pyridin-3-yl}benzenesulfonamide (Compound 3)

[0114]

[0115] The experimental procedure is the same as the synthesis of compound 1 in Example 1, except that 3-bromoquinoline (Q3) is replaced by 5-bromo-1H-pyrrole [2,3-b] pyridine (B3) to obtain the product N-{ 2-Chloro-5-[1H-pyrrole(2,3-b)pyridin-5-yl]pyridin-3-yl}benzenesulfonamide (3). MS(ESI positive ion)m / z:385.84(M+1),1HNMR(400MHz,DMSO-d6):δppm6.551(s,1H),7.595(t,J=8.0Hz,3H),7.695(d ,J=6.8Hz,1H),7.783(d,J=7.2Hz,2H),7.954(d,J=2.4Hz,1H),8.224(d,J=2.0Hz,1H),8.451(d,J =2.0Hz, 1H), 8.613(d, J=2.0Hz, 1H), 10.440(s, 1H), 11.866(s, 1H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of pharmaceuticals and particularly relates to a PI3K inhibitor, a preparation method and application thereof in the pharmacy. The PI3K inhibitor is a compound of the structure shown by the general formula I or medically acceptable salt of the inhibitor. After the PI3K inhibitor is tested with a PI3K biochemical activity test method, the compound has excellent inhibitory activity to PI3K alpha and PI3K gamma, wherein the IC50 values of a plurality of compounds to the PI3K alpha and PI3K gamma reach nanomole grades (smaller than 100 nM). The result shows that the compounds can provide the inhibitor with better effectiveness and selectivity for curing PI3K-acted proliferative disease, and further a targeted drug for curing No. I type diabetes mellitus, lung disease, breast cancer, prostatic cancer, solid tumor, lymphoma, cardiovascular disease, rheumatoid arthritis, leukemia and the like can be hopefully developed. (Please see the general formula I in the description.).

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a PI3K inhibitor, a preparation method thereof and an application in pharmacy. Background technique [0002] Cancer is one of the major diseases that threaten human health. According to the third national cause of death survey released by the Ministry of Health in 2008, cancer has become the first cause of death in my country's urban population. Molecularly targeted anticancer drugs, as new anticancer drugs, act on specific molecular targets of tumor cells, and selectively inhibit the proliferation of tumor cells by taking advantage of the differences between tumor cells and normal cells in many aspects such as genes, enzymes, and signal transduction. , invasion, metastasis and other malignant biological behaviors, thereby producing anti-tumor effects, while having less toxic side effects on normal cells. Therefore, molecularly targeted anticancer drugs rarely produ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/04C07D471/04C07D213/76A61K31/4709A61K31/444A61P35/00A61P35/02A61P3/10A61P19/02A61P29/00A61P17/00A61P9/00
CPCC07D401/04C07D213/76C07D471/04
Inventor 周亚明杨成斌洪辉刘小锋杨永泰凌云贾瑜邓名莉
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com